Clinical Trial Results: Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68) [Phase 4]

View source ↗

Summary

Phase 4 trial results evaluating dapagliflozin on cardiovascular events in acute heart failure, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: The TIMI Study Group | Conditions: Acute Heart Failure, Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2026-06-16